Well, we know that there is a disruption and that as far as the FDA knows it's just the one report so far.
In an administration that frequently gets involved in cover-ups, you can't fault the FDA for trying to disclose as much as they can without causing new problems.
Plus the press release goes on to detail many other areas of FDA's regulatory domain that are also helpful.